CN112480220A - Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis - Google Patents

Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis Download PDF

Info

Publication number
CN112480220A
CN112480220A CN202011390510.6A CN202011390510A CN112480220A CN 112480220 A CN112480220 A CN 112480220A CN 202011390510 A CN202011390510 A CN 202011390510A CN 112480220 A CN112480220 A CN 112480220A
Authority
CN
China
Prior art keywords
thr
protein
lys
asn
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011390510.6A
Other languages
Chinese (zh)
Other versions
CN112480220B (en
Inventor
李海涛
刘志洋
刘荣梅
王静
高继国
张�杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Agricultural University
Original Assignee
Northeast Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Agricultural University filed Critical Northeast Agricultural University
Priority to CN202011390510.6A priority Critical patent/CN112480220B/en
Publication of CN112480220A publication Critical patent/CN112480220A/en
Application granted granted Critical
Publication of CN112480220B publication Critical patent/CN112480220B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44Guanidine; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pest Control & Pesticides (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a Bacillus thuringiensis Sip1Aa protein random recombinant mutant protein, belonging to the technical field of biology. The invention obtains the Sip1Aa high-efficiency soluble insecticidal protein mutant M6 and M8 proteins, respectively changes an amino acid, improves the insecticidal activity of the obtained mutant protein M8 by 4.02 times and the insecticidal activity of M6 by 2.19 times, effectively overcomes the problem of searching a gene with high toxicity of the bacillus thuringiensis expression protein to the bullion, and delays the generation of drug resistance of pests to engineering bacteria and transgenic plants.

Description

Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis
Technical Field
The invention belongs to the technical field of biological control, and particularly relates to random recombinant mutant protein of Bt insecticidal gene with high toxicity to coleoptera agricultural pests.
Background
Bacillus thuringiensis (Bt) is a gram-positive bacterium, widely exists in nature, and generally has a short rod shape, and is single-grown or short-chain. In 1911, the German biologist Bellen (Berlinier) isolated the same bacterium from diseased larvae of Mediterranean pink borer, Scotch, Germany and named Bacillus thuringiensis. The bacillus thuringiensis has been studied for over 100 years, and reports on the bacillus thuringiensis relate to aspects of biomolecular science, cytology, classification nomenclature, effective components of Bt and insecticidal mechanism thereof, and the like, and the research reports are many tens of thousands.
At present, fewer reports on Bt Sip proteins are made at home and abroad. In the course of Donovan et al investigating the insecticidal activity of Bt strains against coleopteran insects, the culture supernatants of some strains were found to be Lethal (LC)50) The gene has insecticidal activity on Colorado Potato Beetle (CPB) larvae at 0.12 (0.09-0.15) mu.g/mL, comprises 1104bp, encodes 367 amino acids, is named as Sip1A, and has 46% of similarity with Mtx3 mosquito killing protein (Donovan W P, Engleman J T, Donovan J C, et al]Appl Microbiol Biotechnol,2006,72(4): 713-719). In 2012, the laboratory cloned and identified sip gene comprising 1038bp and encoding 345 amino acid sequences from Bt strain QZL26, but its insecticidal activity has not been reported (Liu Yangjie, Lihao, Liu Rong Mei, etc.. Bt novel gene sip cloning, expression and bioinformatics analysis [ J]Biotechnological notification 2012(12) 101-. In 2013, Murawska et al applied genome sequencing technology and found that the strain IS5056 contained the sip gene, but they were not studied in depth. In 2015, 1188bp Sip protein which encodes 395 amino acids and is cloned and expressed from Bt strain DQ89 by Zhang jin wave shows that the protein has higher poisoning effect on bulla and LC thereof50The value was 1.542. mu.g/mL (Zhang jin Bo, Liaotao, Liurongmei, etc.. Bt Strain DQ89 sip gene cloning, expression and insecticidal activity analysis [ J]The Chinese journal of biological control 2015,31(4): 598-. In addition, sandmonanthus chevalis clones sip1Aa gene from Bt strain QZL38, constructs its truncated mutant, removes the first 90bp signal peptide, and can produce 37.6kDa soluble eggWhite and tested for LC against bulleyana50The value was 1.051. mu.g/mL (Sha J, Zhang J, Chi B, et al. Sip1Abgene from a native Bacillus thuringiensis strain QZL38 and its induced activity acquisition of collagen bowring Baly [ J].Biocontrol Science&Technology,2018,28(5):459-467.)。
Theoretically, PCR amplification is an exponential growth process, but in practice, the amplification curve of PCR is not a standard "J" shaped exponential curve, but rather a curve that approximates a "S" shape. This occurs because the number of amplification cycles increases with PCR. The amplification scale is exponentially and rapidly increased, and the elements of various PCR reactions such as Taq enzyme, dNTPs, primers, even DNA templates and the like are gradually short of demand, so that the PCR efficiency is lower and lower, and the increase rate of products is also gradually slowed down. When all the raw materials required for PCR are consumed, the PCR is in a plateau phase, and the amount of PCR products is saturated. Due to the complex interaction among various factors, the opportunity and height of different PCR reaction systems entering the platform phase are greatly different.
And obtaining an amplification curve of the plasmid through fluorescent quantitative PCR, detecting the amplification process of the whole PCR, observing a base line phase, a logarithmic phase and a platform phase of PCR reaction, determining the cycle number of PCR entering exponential amplification under the condition of different template amounts, and calculating to obtain the exponential amplification cycle number required for reaching the expected mutation rate. Selecting a plasmid with a proper concentration capable of generating as much product quantity as possible as a template of error-prone PCR, carrying out PCR amplification by using Taq DNA polymerase, carrying out double enzyme digestion reaction with a vector plasmid after PCR product gel is recovered and purified, carrying out T4 ligase connection, then transforming to an escherichia coli LM109 competent cell, screening positive clone, and storing a transformant, thus obtaining the sip1Aa random recombinant library.
In the application, the Sip1Aa mutant protein with high activity is expected to be obtained by a random recombination method, and for the research on key amino acid residues of bacillus thuringiensis playing a poisoning effect on pests, the higher the mutation rate is, the better the mutation rate is, so that the selection of the proper mutation rate is important. In addition, the relationship between the structure and function of insecticidal proteins is studiedIt is generally advisable to study mutations of individual amino acid residues, i.e.about 1.5 base mutations per segment of the gene of interest. If only proteins with significant changes in properties are desired, it is possible to increase the amount of Mg in the PCR system2+The concentration can increase the mutation rate and expand the capacity of the mutation library. Even so, when the number of mutated bases in each segment of the target gene exceeds 6, the protein often loses its original function.
In addition, in previous studies on Cry proteins, a series of mutants were constructed by random mutagenesis, in which the mutants with increased insecticidal activity were all at low mutation frequencies, and when the mutation frequency was too high, most of the mutations were harmful and beneficial mutations could hardly be screened (Vartanian JP, Henry M, Wain-Hobson S. hypermutagenic PCR incorporation of all mutations and a sizeable breeding of transitions. nucleic Acids Res,1996,24(14): 2627) 2631.). Meanwhile, if the mutation frequency is too low, the wild-type protein will occupy the advantages of the mutation library, and the ideal mutants cannot be screened. Therefore, this study selects a low mutation frequency that would expect 1.5 base mutations per segment of the gene of interest, and constructs a random recombinant library of sip1 Aa.
Disclosure of Invention
In order to delay insect resistance and obtain mutant proteins with higher insecticidal activity, the research utilizes an error-prone PCR technology to construct a random recombination library of the Sip1Aa protein, randomly selects 100 positive transformants for sequence determination, and generates 25 mutants in total, which are respectively named as M1-M25. A total of 29 base mutations occurred, with an average of 1.2 base mutations per mutant. Compared with the Sip1Aa protein, the insecticidal activity of the mutant M1(A31, Y118 and D227), M5(K168) and M21(I307) is obviously reduced, the activity is reduced by 4-6 times, meanwhile, the mutant M8(R174S) with improved insecticidal activity on simian beetle is obtained, the activity is improved by 4.02 times, and the activity of the mutant M6(F346V) is improved by 2.19 times, and the research result provides reference for molecular modification of the Sip1Aa protein and research on key sites of the insecticidal activity.
Mutant M8(R174S), the amino acid sequence of which is as shown in SEQ ID No. 3.
A gene encoding the mutant M8 (R174S).
Mutant M6(F346V), the amino acid sequence of which is shown in SEQ ID No. 5.
A gene encoding the mutant M6(F346V) described above.
The gene sequence is shown in SEQ ID No.4 and SEQ ID No. 6.
The mutant SEQ ID No.3 and SEQ ID No.5 show application in killing great ape beetle pests.
The mutant SEQ ID No.3 and SEQ ID No.5 are prepared into an insecticide to kill the great ape beetles.
The invention constructs the random recombination library of the Sip1Aa protein by using the error-prone PCR technology, randomly selects 100 positive transformants for sequence determination, generates 25 mutants in total and is respectively named as M1-M25. A total of 29 base mutations occurred, with an average of 1.2 base mutations per mutant. Compared with wild type Sip1Aa protein, the insecticidal activity of the mutant M1(A31, Y118 and D227), M5(K168) and M21(I307) is obviously reduced, the LC50 value is increased by 4-6 times, and meanwhile, the mutant M8(R174S) with improved insecticidal activity to the simian beetle is obtained, and the LC50 value is reduced by 4 times; and the activity of the M6(F346V) mutant was increased 2.19-fold. The research result provides reference for molecular modification of the Sip1Aa protein and research of key sites of insecticidal activity.
Drawings
FIG. 1 fluorescent quantitative PCR amplification/cycling plot,
FIG. 2 shows the result of PCR amplification,
m: DL2000 DNA Marker, 1-2: the concentration of the pAc19sip1Aa plasmid template is 3.5 ng/. mu.L, 35 and 28 cycles of PCR amplification are carried out respectively; 3-4: plasmid template concentration of pAc19sip1Aa is 35 ng/. mu.L, PCR is respectively amplified for 35 and 13 cycles,
FIG. 3 shows the error-prone PCR product and the enzyme digestion of the vector,
m: DL5000 and DL2000, 1: xho I and EcoR I enzyme digestion plasmid pAc19sip1Aa, then recycling 3kb carrier; 2: after the Xho I and EcoR I enzyme digestion error-prone PCR glue recovery product, a 1kb target band is recovered,
figure 4 shows the distribution of the abrupt points,
FIG. 5 random mutation library protein expression analysis,
M:Premixed Protein Marker(Low),CK-:pUC19,P:pAc19Sip1Aa,1:M 1,2:M 2,3:M 5,4:M 6,5:M 7,6:M 8,7:M 10,8:M 11,9:M 13,10:M 17,11:M 18,12:M 19,13:M 21and 14:M 25,
FIG. 6 analysis of mutation site structure.
Detailed Description
The present invention will be described in further detail with reference to examples.
1. Materials and reagents
1.1 strains and plasmids
The strains and plasmids used in the experiments are detailed in Table 1 and can be distributed to the public.
TABLE 1 strains and plasmids
Figure BDA0002812283950000041
1.2 primers
Random mutation primer
Designing random mutation primers according to the sequence of the sip1Aa gene, introducing Xho I enzyme cutting sites at the 5 'end of an upstream primer, and introducing EcoR I enzyme cutting sites at the 5' end of a downstream primer. The primer sequences are shown in Table 2.
TABLE 2 primer names and sequences
Figure BDA0002812283950000042
1.3 Medium and antibiotics
Liquid LB: tryptone 1%, NaCl 1%, yeast extract 0.5%; ampicillin (Ampicillin) 100mg of Ampicillin (Ampicillin) was dissolved in 1ml of sterile water and diluted 1000-fold for use in 0.22 μm filter sterilization.
1.5 enzymes and Biochemical reagents
Protein Marker was purchased from TaKaRa corporation; 2 × Taq Mix DNA polymerase was purchased from CWBIO; the DNA gel recovery kit was purchased from Axygen; other reagents are domestic analytical pure reagents.
1.6 test insects
The standardized great ape beetle test insect used in the experiment is a gift from the plant protection research of the Chinese academy of agricultural sciences.
2 method of experiment
2.1 plasmid concentration determination
mu.L of the plasmid was collected and the concentration was determined using a NanoDrop apparatus. Plasmid concentration gradients were diluted to 35 ng/. mu.L and 3.5 ng/. mu.L.
2.2 fluorescent quantitative PCR reaction
The plasmid pAc19sip1Aa transformed with E.coli JM109 was used as a template, sip1Aa-Xho I and sip1Aa-EcoR I were used as a primer pair, and qpCR amplification of a sip1Aa gene fragment was performed, and the reaction system was as follows:
Figure BDA0002812283950000051
reaction procedure: pre-denaturation at 95 ℃ for 30s, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 30s, 40 cycles.
2.3 error-prone PCR reactions
A3.5 ng/. mu.L pAc19sip1Aa plasmid is used as a template, sip1Aa-Xho I and sip1Aa-EcoR I are used as primer pairs, and a sip1Aa gene fragment is amplified, wherein the reaction system is as follows:
Figure BDA0002812283950000052
PCR reaction procedure: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 30s, annealing at 59.8 ℃ for 30s, and extension at 72 ℃ for 1 min. 28 cycles of amplification and final extension at 72 ℃ for 10 min.
After the reaction is finished, the target fragment is recovered by glue.
2.4 enzyme digestion
Xho I and EcoRI are used for carrying out double enzyme digestion on pAc19sip1Aa plasmid and error-prone PCR gel recovery products simultaneously, and the reaction system is as follows:
Figure BDA0002812283950000053
Figure BDA0002812283950000061
reaction conditions are as follows: the reaction was carried out at 37 ℃ for 30 min.
After the reaction is finished, the enzyme digestion product is recovered by agarose gel.
2.5 ligation reaction
Connecting the double-restriction enzyme digestion vector fragment pAc19 after gel recovery with the error-prone PCR gel recovery product through T4 ligase, wherein the system is as follows:
Figure BDA0002812283950000062
reaction conditions are as follows: 16 ℃ overnight.
After the reaction, the Escherichia coli JM109 was transformed to be competent, and a random recombinant library was established.
2.6 sequencing and analysis
Screening positive clones in the random recombinant library, and randomly picking 100 positive clones for sequence determination.
2.7 random recombination library protein expression and extraction
(1) Selecting a recombinant single colony to be cultured in 5mL of liquid LB culture medium containing ampicillin at 37 ℃ and 220rpm/min for 12 h;
(2) inoculating into 100mL 2 XLB liquid culture medium according to 1% inoculum size, culturing at 37 deg.C and 220rpm/min for 16 h;
(3) centrifuging at 4 deg.C and 8000rpm/min for 10min, and collecting thallus;
(4) the precipitate was suspended in 5mL of 1 XTE solution;
(5) performing ultrasonic disruption in ice-water bath (80%, 3s, 3s, 10 min);
(6) centrifuging at 4 deg.C and 12000rpm/min for 10min, and collecting supernatant; SDS-PAGE detects protein expression.
(7) Suspending the precipitate with 2% Triton-100, centrifuging at 4 deg.C and 12000rpm for 10min, discarding the supernatant, and repeating for 3 times;
(8) suspending with sterile water, precipitating, centrifuging at 4 deg.C and 12000rpm/min for 10min, and removing supernatant;
(9) the pellet was suspended in 5mL PBS and stored until use.
2.8 SDS-PAGE electrophoresis
The polyacrylamide gel was formulated as shown in Table 3.
TABLE 3 formulation of SDS Polyacrylamide gels
Figure BDA0002812283950000071
Protein sample treatment: mixing 100 mu L of protein sample with 40 mu L of 5 Xloading buffer solution, then carrying out boiling water bath for 10min, and centrifuging at 12000rpm/min for 10 min;
loading and electrophoresis: and (3) taking 10 mu L of supernatant for sample loading, performing 80V pre-electrophoresis for 20min, and changing the condition of 120V electrophoresis until the protein sample is concentrated to a straight line.
Dyeing: after electrophoresis, the gel was removed, placed in a glass dish to which 100mL of SI had been added, heated with a microwave oven over a high fire for 30s, taken out and placed on a shaker, and decolorized at 70rpm/min for 5 min. The SI was decanted off and the gel was transferred to a glass dish to which 100mL SII and 2mL SIII had been added, heated on a microwave oven with a high fire for 30S, removed and placed on a shaker and stained at 70rpm/min for about 20min until a clear band appeared. The gel was removed and transferred to a glass dish containing distilled water and decolorized overnight at 70 rpm/min.
Imaging: the gel is stored by photographing through a gel imaging system.
2.9 insecticidal Activity assay
pAc19-Sip1Aa protein and random recombinant protein were diluted to different concentrations, and the virulence analysis was performed on the simian diabrotica using fresh pakchoi by leaf dip bioassay with the protein expressed from pUC19 in E.coli as negative control. The specific method comprises the following steps:
(1) selecting fresh and uniform-sized pakchoi leaves, cleaning with distilled water, and placing on filter paper for airing;
(2) putting a protein sample to be detected into a sterile culture dish, adding 0.1% household detergent into the sample, soaking the leaves in the protein sample for about 30s, and turning over the leaves once;
(3) placing the leaves on a preservative film for airing;
(4) putting the dried leaves into culture dishes paved with filter paper wetted by sterilized water respectively;
(5) gently inoculating the larva of the great ape concha into the brush pen, inoculating 16 heads of the larva to each leaf, and repeating the treatment for three times;
(6) placing in a biochemical incubator at 27 deg.C, spraying appropriate amount of sterilized water in the incubator in the morning and evening to maintain the humidity of the incubator air, and controlling the light cycle to 14/10 (light/dark);
counting the number of dead insects and the number of live insects in 48h, and calculating the mortality, correcting the mortality and LC by adopting SPSS software50(95% confidence interval).
3 results of the test
3.1 determination of initial template concentration for PCR amplification
The concentration of pAc19sip1Aa plasmid was 268.3 ng/. mu.L as measured by a microspectrophotometer, Narodrop. The plasmid was diluted to 35 ng/. mu.L and 3.5 ng/. mu.L, and 1. mu.L of plasmid was taken as a template, and fluorescence quantitative PCR was performed using sip1Aa-Xho I and sip1Aa-EcoR I as primer pairs, while negative control was performed using water as a template, and each condition was repeated 3 times. The qPCR amplification results are shown in figure 1.
Since different PCR exponential amplification cycles lead to different mutation frequencies, the amplification of the pAc19sip1Aa plasmid was investigated by quantitative fluorescence PCR. According to the results of FIG. 1, when the concentration of pAc19sip1Aa plasmid template was 35 ng/. mu.L, PCR was in the exponential amplification phase at 10-22 cycles; when the concentration of pAc19sip1Aa plasmid template was 3.5 ng/. mu.L, PCR was in the exponential amplification phase at 25-35 cycles.
According to the calculation result, when the initial concentration of the pAc19sip1Aa plasmid template is 35 ng/. mu.L, 13 PCR cycles are needed to obtain the mutation rate of 1.5 bases; when the initial concentration of pAc19sip1Aa plasmid template was 3.5 ng/. mu.L, 28 PCR cycles were required. The results of PCR amplification under these conditions are shown in FIG. 2.
As can be seen from FIG. 2, the amount of PCR product increased with the increase of the number of PCR cycles with the same amount of template before the PCR amplification reached saturation. After the PCR products are subjected to gel recovery, concentration measurement shows that the initial concentration of the pAc19sip1Aa plasmid template is 35 ng/. mu.L, and the concentration of the products obtained by 13 PCR cycles of amplification is obviously lower than that of the products obtained by 28 PCR cycles of amplification, wherein the initial concentration of the pAc19sip1Aa plasmid template is 3.5 ng/. mu.L. For the convenience of subsequent gel recovery, enzyme digestion and other operations, pAc19sip1Aa plasmid template with initial concentration of 3.5 ng/. mu.L and 28 PCR cycles were selected as conditions for establishing random recombination library.
3.2 Generation of random recombinant libraries
The pAc19sip1Aa plasmid at an initial concentration of 3.5 ng/. mu.L was used as a template for error-prone PCR reactions, and after 28 cycles of PCR amplification, the product was recovered in gel. Then carrying out double enzyme digestion on the gel recovery product by using restriction enzymes Xho I and EcoR I, and recovering a target band with the size of 1 kb; at the same time, the pAc19sip1Aa plasmid was double digested with restriction enzymes Xho I and EcoR I, and the vector fragment of 3kb in size was recovered from the gel, as shown in FIG. 3. And connecting the gel recovery products of the two products according to a reaction system of T4 ligase, carrying out overnight reaction at 16 ℃, transforming E.coli JM109 competent cells, screening positive clones, and storing 1000 positive transformants in total to establish the sip1Aa random recombinant library.
3.3 random recombination library sequence analysis
In order to verify the base change of the random mutation target fragment, 100 positive transformants are randomly selected from the random mutation library for sequence determination, and the sequencing result is analyzed. Among them, 25 mutants were subjected to base change and named M1-M25, respectively. The statistics of the nucleotide and amino acid changes in the mutants are shown in Table 4.
TABLE 4 mutant base and amino acid sequences in random recombination libraries
Figure BDA0002812283950000091
Of the 100 transformants sequenced, 11 mutants had nucleotide changes but did not cause amino acid changes. The total number of mutants with nucleotide changes and amino acid changes is 14, accounting for 14%. Mutants with missense mutations were M1, M2, M5, M6, M7, M8, M10, M11, M13, M17, M18, M19, M21 and M25, respectively. Among the 25 mutants obtained, no mutation occurred and no mutation of base insertion and deletion was observed, even though a stop codon was generated after the mutation.
Sequencing analysis of 100 positive transformants showed that 25 mutants out of 100 transformants had base mutations, resulting in 29 nucleotide site mutations (Table 4), and that each mutant had 1.2 base mutations on average, which was substantially identical to the expected 1.5 base mutations per mutant. Of the 29 mutated nucleotide sites, most of the base substitutions occurred AT → GC, accounting for 82.8% of the total mutated sites, with less mutations of guanine and cytosine, only 3.4%, consistent with the previously reported propensity of Taq DNA polymerase to have AT → GC mismatches when performing PCR reactions.
3.4 distribution of abrupt change sites
Statistical analysis of 29 base mutation sites in the random mutation library using Origin 8.0 is shown in FIG. 4. Between 91 bp and 1005bp of the nucleotide sequence of sip1Aa, the base sites with mutation are distributed more uniformly, and no mutation hot spots are found. Except for the 1036 th base, 1 mutation is carried out on each base site. In the mutant M6, the 1036 th thymine is mutated into guanine, so that 346 th phenylalanine is replaced by valine; in the mutant M13, the 1036 th thymine was mutated to cytosine, resulting in the 346 th phenylalanine being mutated to leucine.
3.5 random mutant library protein expression
The proteins expressed by the recombinant strains in the random recombinant library in Escherichia coli JM109 were extracted, and SDS-PAGE analysis of the expression of the mutant proteins with missense mutation was performed, as shown in FIG. 5. Sip1Aa protein expressed under the guidance of cry1Ac promoter is used as a positive control, and pUC19 expressed in escherichia coli is used as a negative control. The results showed that all mutants in the random mutant library were successfully expressed in E.coli, and the expressed product contained 37.6kDa protein of interest, which was identical in size to Sip1Aa protein (FIG. 5).
3.6 measurement of biological Activity
Preliminary activity tests were first carried out on 14 mutants and the results showed that the lethality of the muteins M6(F346V) and M8(R174S) to bullosa was higher than that of the pAcSip1Aa protein and that the insecticidal activity of the muteins M1(A31G, Y118C, D227E), M2(N305I, T324A), M5(K168R) and M21(I307T) to bullosa was lower than that of pAcSip1 Aa. The muteins M7(F89L), M10(K168N), M11(I45V), M13(F364L), M17(D141G), M18(N317D), M19(K193K, E235G), M25(N75S) and pAcSip1Aa have no significant difference in the lethality to bullous apes.
TABLE 5 insecticidal results of Sip1Aa random muteins against Bullenia apetala
Figure BDA0002812283950000101
Figure BDA0002812283950000111
Mutants M1, M2, M5, M6, M8 and M21 were purified and used for counterscreening of the apes beetles, with PBS buffer as negative control. The protein concentration of the rescreened solution is set to be six concentration gradients of 0.1 mu g/mL, 1 mu g/mL, 5 mu g/mL, 10 mu g/mL, 20 mu g/mL and 50 mu g/mL, three times of repetition is set for each concentration, 16 head worms are inoculated in each repetition, after the solution is cultured in a climatic chamber at the temperature of 27 ℃ for 48 hours, the death condition of the insects is counted, and LC is calculated50The value is obtained. The results of the biological activity assay rescreening are shown in Table 5.
TABLE 5 quantitative determination of the biological Activity of the Sip1Aa random mutein against the great Simian Blastoma
Figure BDA0002812283950000112
As can be seen from Table 6, the activity of the mutant M8 is greatly improved, the insecticidal activity against the great ape beetle is obviously better than that of pAc19Sip1Aa, the activity is improved by 4.02 times, and the insecticidal activity against the great ape beetle is improved by 2.19 times by the mutant M6. The insecticidal activity of the mutants M2 on the great ape beetle is slightly lower than that of pAc19Sip1Aa, M1, M5 and M21 on the great ape beetle, and the insecticidal activity is obviously lower than that of pAc19Sip1Aa protein, and is reduced by 4 times, 5 times and 6 times.
3.7 analysis of mutant site Structure
The structural analysis of the M1(A31, Y118, D227), M5(K168), M8(R174) and M21(I307) sites of mutants in a random recombination library of Sip1Aa protein was performed using PDB Viewer software.
Y118 and D260 are capable of forming two intramolecular hydrogen bonds, each having a bond length of
Figure BDA0002812283950000123
And
Figure BDA0002812283950000124
(a in FIG. 6). When threonine 118 is replaced by cysteine, C118 and D260 can only form a hydrogen bond with the length of
Figure BDA0002812283950000125
(b in FIG. 6). D227 and Y176 form two hydrogen bonds with the bond lengths of
Figure BDA0002812283950000121
And
Figure BDA0002812283950000122
(c in FIG. 6). When the 227 th aspartic acid is mutated into glutamic acid, E227 can form two hydrogen bonds with Y176, but the bond length is changed, namely
Figure BDA0002812283950000126
And
Figure BDA0002812283950000127
as shown at d in fig. 6. The mutation of A31G had no significant effect on the structure of the Sip1Aa protein. These mutations result in a reduction in the stability of mutant M1 compared to the wild-type Sip1Aa protein, resulting in a reduction in insecticidal activity against the macaca apelta.
The two bonds of the K168 and V236 forms in mutant M5 are of length
Figure BDA0002812283950000128
And
Figure BDA0002812283950000129
hydrogen bonds (e in fig. 6). When lysine 168 was replaced by arginine, the hydrogen bond disappeared (f in FIG. 6). The hydrogen bond formed by I307 and T306 in mutant M21 is as long as
Figure BDA00028122839500001210
(i in FIG. 6). After I307 was substituted with threonine, the hydrogen bond disappeared. Hydrogen bonding can maintain steric stabilization. The mutants M5 and M21 lose stable intramolecular hydrogen bonds, possibly resulting in the change of the spatial structure of the protein and reducing the insecticidal activity of the protein on the great ape beetle.
The arginine at position 174 in mutant M8 is located on the β 11 fold, as indicated by g in FIG. 6. When the basic arginine at position 174 was replaced with a neutral serine (h in FIG. 6), the mutant protein was increased 4-fold compared to the wild-type Sip1Aa protein. It is possible that at this position, neutral amino acids are more favorable for the Sip1Aa protein to exert a poisoning effect in the great ape beetle.
4 conclusion
The invention adopts the random recombination technology to transform the Sip1Aa protein, the insecticidal activity of the mutants M8 and M6 is obviously improved, the activity of the mutant M8 is improved by 4.02 times, and the insecticidal activity of the mutant M6 on the great ape beetle is improved by 2.19 times. In addition, because the promoter of the vector is changed, the expression quantity of the protein M8 and M6 of the Sip1Aa mutant is improved, the solubility is high, and the stability is good.
Sequence listing
<110> northeast university of agriculture
<120> Sip1Aa protein random recombinant mutant protein
<141> 2020-12-02
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 364
<212> PRT
<213> Bacillus thuringiensis (Bacillus thuringiensis)
<400> 1
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Arg Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Phe Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 2
<211> 1095
<212> DNA
<213> Bacillus thuringiensis (Bacillus thuringiensis)
<400> 2
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagattatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacatttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095
<210> 3
<211> 364
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 3
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Ser Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Phe Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 4
<211> 1095
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagtttatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacatttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095
<210> 5
<211> 364
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 5
Met Lys Tyr Lys Phe Ser Lys Val Val Lys Cys Thr Leu Pro Ala Leu
1 5 10 15
Met Ile Thr Thr Phe Val Thr Pro Ser Met Ala Val Phe Ala Ala Glu
20 25 30
Thr Lys Ser Pro Asn Leu Asn Ala Ser Gln Gln Ala Ile Thr Pro Tyr
35 40 45
Ala Glu Ser Tyr Ile Asp Thr Val Gln Asp Arg Met Lys Gln Arg Asp
50 55 60
Arg Glu Ser Lys Leu Thr Gly Lys Pro Ile Asn Met Gln Glu Gln Ile
65 70 75 80
Ile Asp Gly Trp Phe Leu Ala Arg Phe Trp Ile Phe Lys Asp Gln Asn
85 90 95
Asn Asn His Gln Thr Asn Arg Phe Ile Ser Trp Phe Lys Asp Asn Leu
100 105 110
Ala Ser Ser Lys Gly Tyr Asp Ser Ile Ala Glu Gln Met Gly Leu Lys
115 120 125
Ile Glu Ala Leu Asn Asp Met Asp Val Thr Asn Ile Asp Tyr Thr Ser
130 135 140
Lys Thr Gly Asp Thr Ile Tyr Asn Gly Ile Ser Glu Leu Thr Asn Tyr
145 150 155 160
Thr Gly Thr Thr Gln Lys Met Lys Thr Asp Ser Phe Gln Arg Asp Tyr
165 170 175
Thr Lys Ser Glu Ser Thr Ser Val Thr Asn Gly Leu Gln Leu Gly Phe
180 185 190
Lys Val Ala Ala Lys Gly Val Val Ala Leu Ala Gly Ala Asp Phe Glu
195 200 205
Thr Ser Val Thr Tyr Asn Leu Ser Ser Thr Thr Thr Glu Thr Asn Thr
210 215 220
Ile Ser Asp Lys Phe Thr Val Pro Ser Gln Glu Val Thr Leu Ser Pro
225 230 235 240
Gly His Lys Ala Val Val Lys His Asp Leu Arg Lys Met Val Tyr Phe
245 250 255
Gly Thr Gln Asp Leu Lys Gly Asp Leu Lys Val Ser Phe Asn Asp Lys
260 265 270
Glu Ile Val Gln Lys Phe Ile Tyr Pro Asn Tyr Arg Ser Ile Asp Leu
275 280 285
Ser Asp Ile Arg Lys Thr Met Ile Glu Ile Asp Lys Trp Asn His Val
290 295 300
Asn Thr Ile Asp Phe Tyr Gln Leu Val Gly Val Lys Asn His Ile Lys
305 310 315 320
Asn Gly Asp Thr Leu Tyr Ile Asp Thr Pro Ala Glu Phe Thr Phe Asn
325 330 335
Gly Ala Asn Pro Tyr Tyr Arg Ala Thr Val Thr Glu Tyr Asp Glu Asn
340 345 350
Gly Asn Pro Val Gln Thr Lys Ile Leu Ser Gly Asn
355 360
<210> 6
<211> 1095
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgaaataca agttttcaaa agtcgttaag tgtactttac cagctttaat gattactaca 60
ttcgttactc caagtatggc agtttttgcc gcagaaacca agtcgccaaa tctaaatgca 120
tctcaacaag caataactcc atatgctgaa tcttatattg atacggttca agatagaatg 180
aaacaaagag atagggaatc aaaactaact ggtaagccaa taaatatgca agaacaaata 240
atagatggat ggtttttagc tagattctgg atatttaaag atcaaaataa caatcatcaa 300
acaaatagat ttatatcctg gtttaaagat aatcttgcta gttcgaaggg gtatgacagt 360
atagcagaac aaatgggctt aaaaatagaa gcattaaatg atatggatgt aacaaatatt 420
gattatacat ctaaaacagg tgataccata tataatggaa tttctgaact aacaaattat 480
acaggaacaa cccaaaaaat gaaaaccgat agttttcaaa gagattatac aaaatctgaa 540
tccacttcag taacaaatgg gttacaatta ggatttaaag ttgctgctaa gggagtagtt 600
gcattagcag gtgcagattt tgaaacaagt gttacctata atttatcatc tactacaact 660
gaaacaaata caatatcgga taagtttact gttccatctc aagaagttac attatcccca 720
ggtcataaag cagtagtgaa acatgatttg agaaaaatgg tgtattttgg gactcaagat 780
ttaaagggtg atttaaaagt aagttttaat gataaagaga ttgtacaaaa atttatttat 840
ccaaattata gatcaattga tttatctgat attcgtaaaa caatgattga aattgataaa 900
tggaatcatg taaataccat tgacttttat caattagttg gagttaaaaa tcatataaaa 960
aatggtgata ctttatatat agataccccg gccgaattta catttaatgg agctaatcca 1020
tattatagag caacagttac agaatacgac gagaacggaa atcctgttca aacaaagatt 1080
ttaagtggaa attaa 1095

Claims (10)

1. The amino acid sequence of the mutant M8 is shown in SEQ ID No. 3.
2. A gene encoding the mutant M8 of claim 1.
3. The gene of claim 2, wherein the nucleotide sequence is shown in SEQ ID No. 4.
4. Use of the mutant M8 according to claim 1 for killing a pest simian beetle.
5. The use according to claim 4, wherein the mutant M8 of claim 1 is formulated as an insecticide against bulleyaconitum apetalum.
6. The amino acid sequence of the mutant M6 is shown in SEQ ID No. 5.
7. A gene encoding the mutant M6 of claim 6.
8. The gene of claim 7, wherein the nucleotide sequence is shown in SEQ ID No. 6.
9. Use of the mutant M6 according to claim 6 for killing a pest simian beetle.
10. The use according to claim 9, wherein the mutant M6 according to claim 6 is formulated as an insecticide against bulleyana.
CN202011390510.6A 2020-12-02 2020-12-02 Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis Active CN112480220B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011390510.6A CN112480220B (en) 2020-12-02 2020-12-02 Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011390510.6A CN112480220B (en) 2020-12-02 2020-12-02 Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis

Publications (2)

Publication Number Publication Date
CN112480220A true CN112480220A (en) 2021-03-12
CN112480220B CN112480220B (en) 2021-10-12

Family

ID=74939017

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011390510.6A Active CN112480220B (en) 2020-12-02 2020-12-02 Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis

Country Status (1)

Country Link
CN (1) CN112480220B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060191034A1 (en) * 2003-07-07 2006-08-24 Baum James A Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
US20080040827A1 (en) * 2003-12-16 2008-02-14 Judith Donovan Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor
CN101255432A (en) * 2008-03-03 2008-09-03 创世纪转基因技术有限公司 Artificial reconstruction synthetic pesticidal gene as well as encoding protein and use thereof
US20100199383A1 (en) * 2008-09-18 2010-08-05 Pioneer Hi-Bred International, Inc. Novel Bacillus Thuringiensis Gene with Coleopteran Activity
CN102718872A (en) * 2012-06-20 2012-10-10 中国农业科学院植物保护研究所 Bacillus thuringiensis gene combination and engineering bacteria and preparation method thereof
CN104388349A (en) * 2014-11-21 2015-03-04 东北农业大学 Insecticidal gene sip1A secreted by bacillus thuringiensis as well as expression protein and application thereof
CN106632624A (en) * 2016-09-21 2017-05-10 中国农业科学院植物保护研究所 Insecticide protein and nucleic acid, preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060191034A1 (en) * 2003-07-07 2006-08-24 Baum James A Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
CN1849397A (en) * 2003-07-07 2006-10-18 孟山都技术有限公司 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
US20080040827A1 (en) * 2003-12-16 2008-02-14 Judith Donovan Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor
CN101255432A (en) * 2008-03-03 2008-09-03 创世纪转基因技术有限公司 Artificial reconstruction synthetic pesticidal gene as well as encoding protein and use thereof
US20100199383A1 (en) * 2008-09-18 2010-08-05 Pioneer Hi-Bred International, Inc. Novel Bacillus Thuringiensis Gene with Coleopteran Activity
CN102718872A (en) * 2012-06-20 2012-10-10 中国农业科学院植物保护研究所 Bacillus thuringiensis gene combination and engineering bacteria and preparation method thereof
CN104388349A (en) * 2014-11-21 2015-03-04 东北农业大学 Insecticidal gene sip1A secreted by bacillus thuringiensis as well as expression protein and application thereof
CN106632624A (en) * 2016-09-21 2017-05-10 中国农业科学院植物保护研究所 Insecticide protein and nucleic acid, preparation method and application thereof

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
JING WANG 等: ""In silico Structure-Based Investigation of Key Residues of Insecticidal Activity of Sip1Aa Protein"", 《FRONT MICROBIOL》 *
JOAQUÍN GOMIS-CEBOLLA 等: ""A Genomic and Proteomic Approach to Identify and Quantify the Expressed Bacillus thuringiensis Proteins in the Supernatant and Parasporal Crystal"", 《TOXINS (BASEL)》 *
PETIT,L. 等: ""ETX/MTX2 family pore-forming toxin [Bacillus thuringiensis]"", 《GENBANK》 *
YUE-MING DING 等: ""Construction and analysis of Sip1Aa insecticidal protein random recombination library"", 《JOURNAL OF ASIA-PACIFIC ENTOMOLOGY》 *
ZHANG,J.B. 等: ""secreted coleopteran active protein [Bacillus thuringiensis]"", 《GENBANK》 *
刘艳杰 等: ""Bt新型基因sip的克隆、表达和生物信息学分析"", 《生物技术通报》 *
张金波 等: ""Bt菌株DQ89的sip基因的克隆、表达及杀虫活性分析"", 《中国生物防治学报》 *
王静: ""苏云金芽胞杆菌Sip1Aa蛋白杀虫活性关键位点的研究"", 《中国优秀硕士学位论文全文数据库(电子期刊) 农业科技辑》 *
雷会霄: ""苏云金芽孢杆菌的分离鉴定及杀虫基因的克隆"", 《中国优秀硕士学位论文全文数据库(电子期刊) 农业科技辑》 *

Also Published As

Publication number Publication date
CN112480220B (en) 2021-10-12

Similar Documents

Publication Publication Date Title
CA2782300C (en) Gene dro1 controlling deep-rooted characteristics of plant and utilization of same
GB2187462A (en) Expression of genes in plants and plant cell cultures using promotors from root-nodule specific genes
AU2015297522B2 (en) Plant body ideal for high-density planting and use thereof
CN110066322B (en) Bt protein Cyt2-like and gene and application thereof
CN108250279B (en) Application of heat shock protein Hsp17.6CII in regulation and control of saline-alkali tolerance of plants
CN112480220B (en) Random recombinant mutant protein of Sip1Aa protein of bacillus thuringiensis
CN110938118A (en) Plant immune activation protein PC2 secreted by phytophthora infestans and application thereof
CN110894221A (en) Strawberry maturation associated transcription factor gene FaNAC2 and application thereof
CN111909252B (en) Ginseng PgbHLH149 transcription factor and application thereof
CN111793118A (en) CheY2 mutant protein and application thereof
CN109734789B (en) Migratory locust FK506 binding protein 46 and coding gene and application thereof
CN107326035A (en) A kind of adjusting and controlling rice grain type and the deubiquitination enzyme gene UBP5 of leaf color and its application
CN110894218A (en) Plant immune activator protein SCR50 secreted by phytophthora infestans and application thereof
RU2020113297A (en) DNA vaccine against SARS-CoV-2 virus based on gene therapy DNA vector GDTT1.8NAS12, method of its production, strains carrying gene therapy DNA vectors, method of their production, method of industrial-scale production of gene therapy DNA vectors
CN114807172B (en) Salt response corn functional gene
CN114456244B (en) Gene OsR49841018986900.01 and application of encoded protein in regulation of rice chalkiness
CN112480219B (en) Sip1Aa soluble insecticidal protein mutant
CA1310923C (en) Dna encoding [asp --] and [lys -, asp --] thaumatin i
JPH0829100B2 (en) A novel hybrid Bacillus thuringiensis gene plasmid and transformed Pseudomonas fluorescens
CN108794609B (en) Chlorophytum comosum root nitrate transport protein CcNPF8.1 and coding gene and application thereof
LU501420B1 (en) Bacillus sj110 strain, insecticidal protein, vip3-like insecticidal gene, and use thereof
CN112940135A (en) Fusion protein, amino acid sequence, coding nucleotide sequence, preparation method and application thereof
CN108822218B (en) Fusion protein of spider toxin peptide and bacillus thuringiensis insecticidal crystal protein and application thereof
CN103103204A (en) Bt cry54Ab1 operon gene, protein encoded by gene and application of gene or protein
CN103525835A (en) Bt Cry71Aa1 gene and coded protein thereof and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant